Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
出版信息
Lancet. 1978 Nov 11;2(8098):1042.
PMID:82048
Abstract
摘要
相似文献
1
Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
Lancet. 1978 Nov 11;2(8098):1042.
2
Prognostic factors in nonseminomatous testicular cancer.非精原细胞瘤性睾丸癌的预后因素。
Prog Clin Biol Res. 1985;203:271-86.
3
Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
Tumour Biol. 1987;8(2-3):106-8.
4
Radioimmunodetection of primary and secondary germ cell tumors.原发性和继发性生殖细胞肿瘤的放射免疫检测
Prog Clin Biol Res. 1985;203:127-38.
5
Testicular cancer: role of biological tumor markers.
Cancer Treat Rev. 1979 Dec;6(4):217-21. doi: 10.1016/s0305-7372(79)80038-9.
6
Testicular cancer. Clinical practice guidelines in oncology.睾丸癌。肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2006 Nov;4(10):1038-58. doi: 10.6004/jnccn.2006.0087.
7
8
Testicular germ cell tumors: diagnosis, management, and the potential for cure.睾丸生殖细胞肿瘤：诊断、管理及治愈潜力
Cancer Clin Trials. 1978 Winter;1(4):247-71.
9
Management of clinical stage I nonseminomatous germ cell testicular cancer.临床I期非精原细胞性生殖细胞睾丸癌的管理
Urol Clin North Am. 2007 May;34(2):137-48; abstract viii. doi: 10.1016/j.ucl.2007.02.001.
引用本文的文献
1
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.除了肝癌，甲胎蛋白在临床实践中还有更多的应用场景。
Front Oncol. 2023 Sep 15;13:1231420. doi: 10.3389/fonc.2023.1231420. eCollection 2023.
Zotero 插件